FDA inspection
Renalytix AI, Inc.: FDA inspection ending Mar 1, 2022
FDA inspection 1165285 · No Action Indicated (NAI) · Long Island City, NY
Key facts
| Inspection ID | 1165285 |
|---|---|
| Firm | Renalytix AI, Inc. |
| FEI number | 3018739912 |
| Address | 101 6th Ave Fl 3 Rm 324 |
| City | Long Island City |
| State | NY |
| ZIP | 11101 |
| Country | United States |
| Fiscal year | 2022 |
| Inspection end date | Mar 1, 2022 |
| Classification | No Action Indicated (NAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data